SCNX NASDAQ
Scienture Holdings, Inc.
1W: -45.0%
1M: -58.7%
3M: -55.8%
YTD: -70.7%
1Y: -82.5%
$0.16
-0.02 (-10.33%)
Weekly Expected Move ±16.4%
$0
$0
$0
$0
$0
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
46 relationships46
As Filer
counterparties named
0
As Counterparty
mentioned by others
6
Rel. Types
2022-02-16
Earliest Filing
2025-10-03
Latest Filing
target: 15
acquirer: 13
partner: 10
investor: 3
customer: 3
supplier: 2
Counterparties (Filed by SCNX)
46 relationshipsCompanies named in SCNX's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| Arena Finance Markets, LP | AREN | investor | Holder of 10% original issue discount secured debentures converted to common stock | 2025-10-03 | View |
| Arena Special Opportunities III LP | AREN | investor | Holder of 10% original issue discount secured debentures converted to common stock | 2025-10-03 | View |
| SCIENTURE HOLDINGS, INC. | SCNX | target | Seller of 100% membership interest in Integra Pharma Solutions LLC | 2025-04-11 | View |
| Integra Pharma Solutions LLC | — | target | Target company whose membership interest is being sold | 2025-04-11 | View |
| TOLLO HEALTH, LLC. | — | acquirer | Buyer of 100% membership interest in Integra Pharma Solutions LLC | 2025-04-11 | View |
| Scienture Holdings, Inc. | SCNX | acquirer | Company entering into Independent Contractor Agreement for CFO services | 2025-03-13 | View |
| EMS Consulting Services, LLC | — | partner | Contractor providing CFO services to Scienture Holdings, Inc. | 2025-03-13 | View |
| Kindeva Drug Delivery L.P. | — | partner | Parent company of Summit Biosciences Inc. | 2025-03-10 | View |
| Scienture, LLC | SCNX | customer | Exclusive licensee and commercialization partner for the Product in the Territory. | 2025-03-10 | View |
| Scienture Holdings, Inc. | SCNX | partner | Parent company of Scienture, LLC. | 2025-03-10 | View |
| Summit Biosciences Inc. | — | supplier | Developer and manufacturer of the Product (REZENOPY) granting exclusive commercialization rights. | 2025-03-10 | View |
| TRxADE HEALTH, INC. | — | acquirer | Parent company acquiring Scienture, Inc. in a merger transaction. | 2024-07-31 | View |
| Scienture, Inc. | SCNX | target | Target company being acquired by TRxADE HEALTH, INC. in a merger transaction. | 2024-07-31 | View |
| TRXADE HEALTH INC. | — | partner | Parent company providing guaranty for specific sections of the agreement | 2024-02-16 | View |
| MICRO MERCHANT SYSTEMS, INC. | — | acquirer | Buyer of assets in the Asset Purchase Agreement | 2024-02-16 | View |
| TRXADE, INC. | — | target | Seller of assets in the Asset Purchase Agreement | 2024-02-16 | View |
| Sapentia | — | partner | Company involved in a separate purchase agreement with Superlatus | 2024-01-11 | View |
| Foods Merger Sub, Inc. | — | acquirer | Wholly owned subsidiary of TRxADE Health, Inc. used for merger | 2024-01-11 | View |
| Prestige Farms, Inc. | — | target | Company whose acquisition by Superlatus was the condition precedent for the merger | 2024-01-11 | View |
| Superlatus Inc. | — | target | Target company breaching obligations regarding Prestige Farms acquisition | 2024-01-11 | View |
| TRxADE Health, Inc. | TRXA | acquirer | Parent company entering merger agreement amendment | 2024-01-11 | View |
| Superlatus PD Holding Company | — | supplier | Manufacturer and supplier of food, beverage, and household products. | 2023-10-13 | View |
| Rainforest Distribution Corp | — | customer | Exclusive distributor of Supplier's products in the Territory. | 2023-10-13 | View |
| TRxADE Health, Inc. | — | acquirer | Parent company acquiring Superlatus Inc. in a merger transaction. | 2023-07-31 | View |
| Superlatus Inc. | — | target | Target company being acquired by TRxADE Health, Inc. in a merger. | 2023-07-31 | View |
| Superlatus Foods, Inc. | — | target | Operating name of Superlatus Inc. referenced in contact information. | 2023-07-31 | View |
| TRXADE HEALTH, INC. | MEDS | acquirer | Acquiring company in the merger transaction. | 2023-07-14 | View |
| FOODS MERGER SUB, INC. | — | partner | Wholly owned subsidiary of MEDS used to effect the merger. | 2023-07-14 | View |
| Superlatus Inc. | — | target | Target company being acquired in the merger. | 2023-07-14 | View |
| TRxADE Health, Inc. | — | acquirer | Acquiring Superlatus Foods, Inc. in a merger transaction. | 2023-06-23 | View |
| Superlatus Foods, Inc. | — | target | Target company being acquired by TRxADE Health, Inc. | 2023-06-23 | View |
| Sapientia, Inc. | — | partner | Company whose equity Superlatus Foods, Inc. must acquire as a condition to the merger. | 2023-06-23 | View |
| Superlatus Foods, Inc. | — | target | Target company in acquisition agreement | 2023-06-23 | View |
| TRxADE Health, Inc. | — | acquirer | Acquiring company in acquisition agreement | 2023-06-23 | View |
| Wood Sage, LLC | — | acquirer | Purchasing 100% of the membership interest in Alliance Pharma Solutions, LLC | 2023-01-23 | View |
| Alliance Pharma Solutions, LLC | — | target | Target company whose 100% membership interest is being sold | 2023-01-23 | View |
| TRxADE HEALTH, Inc. | — | target | Selling 100% of its membership interest in Alliance Pharma Solutions, LLC | 2023-01-23 | View |
| TRxADE HEALTH, INC. | — | target | Company entering placement agency agreement for securities offering | 2022-10-07 | View |
| Maxim Group LLC | MMS | partner | Placement agent for the securities offering | 2022-10-07 | View |
| TRxADE HEALTH Inc. | — | partner | Company issuing common stock in the agreement | 2022-09-13 | View |
| White Lion Capital LLC | — | investor | Investor purchasing common stock from the Company | 2022-09-13 | View |
| Integra Pharma Solutions | — | customer | Integra Pharma Solutions is the Debtor whose obligations to McKesson are guaranteed by the Guarantor. | 2022-03-11 | View |
| McKesson Corporation | MCK | acquirer | McKesson Corporation is the beneficiary of the guaranty and the creditor extending credit to the Debtor. | 2022-03-11 | View |
| McKesson Corporation | MCK | acquirer | McKesson Corporation is the beneficiary of the guaranty and the entity extending credit to the Debtor. | 2022-03-04 | View |
| TRxADE HEALTH, Inc | — | target | TRxADE HEALTH, Inc is the Debtor whose obligations are guaranteed by the Guarantor to McKesson Corporation. | 2022-03-04 | View |
| SOSRx, LLC | — | partner | — | 2022-02-16 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-09-14 | Regulation FD; Exhibits | View | |
| 2026-08-20 | Earnings Release; Exhibits | View | |
| 2026-05-29 | Officer/Director Change | View | |
| 2026-05-22 | Earnings Release; Exhibits | View | |
| 2026-05-05 | Regulation FD; Exhibits | View | |
| 2026-05-01 | Material Agreement; Financial Obligation; Exhibits | Agreement | View |
| 2025-11-18 | Regulation FD Disclosure; Financial Statements and Exhibits | View | |
| 2025-11-14 | Submission of Matters to a Vote of Security Holders; Financial Statements and Exhibits | View | |
| 2025-11-13 | Other Events; Financial Statements and Exhibits | View | |
| 2025-10-30 | Other Events; Financial Statements and Exhibits | View | |
| 2025-10-24 | Entry into Material Definitive Agreement; Financial Statements and Exhibits | Agreement | View |
| 2025-10-17 | Notice of Delisting or Transfer; Financial Statements and Exhibits | View | |
| 2025-10-16 | Entry into Material Definitive Agreement; Termination of Material Definitive Agreement; Creation of | Agreement | View |
| 2025-10-06 | Amendments to Articles of Incorporation or Bylaws; Financial Statements and Exhibits | View | |
| 2025-10-03 | Entry into Material Definitive Agreement; Financial Statements and Exhibits | Agreement | View |
| 2025-09-23 | Entry into Material Definitive Agreement; Financial Statements and Exhibits | Agreement | View |
| 2025-08-15 | Entry into Material Definitive Agreement; Unregistered Sales of Equity Securities; Regulation FD Dis | Agreement | View |
| 2025-07-24 | Entry into Material Definitive Agreement; Regulation FD Disclosure; Financial Statements and Exhibit | Agreement | View |
| 2025-07-03 | Entry into Material Definitive Agreement; Financial Statements and Exhibits | Agreement | View |
| 2025-05-22 | Termination of Material Definitive Agreement; Notice of Delisting or Transfer; Departure/Election of | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR